Canandaigua National Corp’s ResMed RMD Stock Holding History

Canandaigua National Corp’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$236K	Buy	1,132 +3	+0.3%	+$659	0.04%	226
2022 Q3	$246K	Sell	1,129 -3	-0.3%	-$683	0.04%	217
2022 Q2	$237K	Sell	1,132 -11	-1%	-$2.34K	0.04%	219
2022 Q1	$277K	Sell	1,143 -4	-0.3%	-$968	0.04%	225
2021 Q4	$299K	Sell	1,147 -15	-1%	-$3.89K	0.04%	231
2021 Q3	$306K	Sell	1,162 -176	-13%	-$48.1K	0.05%	213
2021 Q2	$330K	Sell	1,338 -120	-8%	-$25.2K	0.05%	206
2021 Q1	$283K	Sell	1,458 -141	-9%	-$28.3K	0.05%	222
2020 Q4	$340K	Sell	1,599 -58	-4%	-$11.6K	0.06%	198
2020 Q3	$284K	Sell	1,657 -190	-10%	-$35.1K	0.05%	210
2020 Q2	$355K	Buy	+1,847	New	+$302K	0.07%	181

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Canandaigua National Corp's RMD Position: Q4 2022 in Review

Canandaigua National Corp increased its ResMed (RMD) stake by 0.27% in Q4 2022, buying an estimated $659 and bringing the position to 1,132 shares worth $236K. The position accounts for 0.04% of the portfolio, ranked #226.

Canandaigua National Corp first reported a position in RMD in Q2 2020 and has held it in 11 quarters since. The position peaked at $355K in Q2 2020. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

Canandaigua National Corp held 1,132 shares of ResMed worth $236K as of Q4 2022.
Canandaigua National Corp bought 3 ResMed shares in Q4 2022, an estimated $659.
ResMed made up 0.04% of Canandaigua National Corp's portfolio in Q4 2022, its #226 holding.
Canandaigua National Corp first reported a position in ResMed in Q2 2020 and has held it in 11 quarters since.
Canandaigua National Corp's ResMed position peaked at $355K in Q2 2020.
731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Canandaigua National Corp's 13F filing for Q4 2022, filed 25 Jan 2023.